Literature DB >> 23651182

Drug-induced lupus and autoimmune hepatitis secondary to infliximab for psoriasis.

Lucy J Dang1, John S Lubel, Shyamalar Gunatheesan, Patrick Hosking, John Su.   

Abstract

We describe a case of previously unreported autoimmune hepatitis and lupus-like syndrome induced by infliximab treatment for chronic plaque psoriasis. The condition resolved after withdrawal of infliximab, with the liver injury having been reversed and minimal periportal fibrosis. In a two-part discussion we review the current literature on the pharmacology of infliximab and provide recommendations for management of infliximab side effects.
© 2013 The Authors. Australasian Journal of Dermatology © 2013 The Australasian College of Dermatologists.

Entities:  

Keywords:  adverse drug reaction; dermatology; gastroenterology; hepatitis; psoriasis

Mesh：

Substances：

Year:  2013        PMID： 23651182     DOI： 10.1111/ajd.12054

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN： 0004-8380            Impact factor:   2.875


  10 in total

Review 1.  Hepatotoxicity Associated with the Use of Anti-TNF-α Agents.

Authors:  Joshua B French; Maurizio Bonacini; Marwan Ghabril; David Foureau; Herbert L Bonkovsky
Journal:  Drug Saf       Date:  2016-03       Impact factor: 5.606

Review 2.  Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease.

Authors:  Ersilia M DeFilippis; Sonal Kumar
Journal:  Dig Dis Sci       Date:  2015-05-22       Impact factor: 3.199

Review 3.  Autoimmune hepatitis.

Authors:  Farhad Sahebjam; John M Vierling
Journal:  Front Med       Date:  2015-03-06       Impact factor: 4.592

Review 4.  Diverse patterns of anti-TNF-α-induced lupus: case series and review of the literature.

Authors:  Ora Shovman; Shalev Tamar; Howard Amital; Abdulla Watad; Yehuda Shoenfeld
Journal:  Clin Rheumatol       Date:  2017-10-23       Impact factor: 2.980

5.  Hepatitis and Lupus-Like Syndrome during Infliximab Therapy for Psoriasis.

Authors:  Hassan Riad; Samya Abu Shaikha; Hamda Al Ansari; Khalifa Al Naama; Hussein Al Sada; Mariam Al Mansoori
Journal:  Case Rep Dermatol       Date:  2013-08-14

Review 6.  Novel Immunotherapies for Autoimmune Hepatitis.

Authors:  Shamir Cassim; Marc Bilodeau; Catherine Vincent; Pascal Lapierre
Journal:  Front Pediatr       Date:  2017-01-26       Impact factor: 3.418

Review 7.  Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease.

Authors:  My-Linh Tran-Minh; Paula Sousa; Marianne Maillet; Matthieu Allez; Jean-Marc Gornet
Journal:  World J Hepatol       Date:  2017-05-08

Review 8.  Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events.

Authors:  Smriti Subedi; Yu Gong; Youdong Chen; Yuling Shi
Journal:  Drug Des Devel Ther       Date:  2019-07-23       Impact factor: 4.162

9.  Autoimmune Hepatitis Triggered by Anti-TNF-α Therapy.

Authors:  Satoshi Nakayama
Journal:  Case Rep Med       Date:  2013-09-08

10.  Infliximab-induced autoimmune hepatitis requiring liver transplantation.

Authors:  Frederick Wong; Bashaar Al Ibrahim; Joanna Walsh; Karim Qumosani
Journal:  Clin Case Rep       Date:  2019-09-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.